COVID-19 in children across three Asian cosmopolitan regions
Gilbert T. Chua, Xiaoli Xiong, Eun Hwa Choi, Mi Seon Han, Sung Hee Chang, Byoung Lo Jin, Eun Joo Lee, Baek Nam Kim, Min Kyoung Kim, Kihyun Doo, Ju‐Hee Seo, Yae Jean Kim, Yeo Jin Kim, Ji Young Park, Sun Bok Suh, Hyunju Lee, Eun Young Cho, Dong Hyun Kim, Jong Min Kim, Hye Young Kim, Su Eun Park, Joon Kee Lee, Dae Sun Jo, Seung Man Cho, Jae Hong Choi, Kyo Jin Jo, Young June Choe, Ki Hwan Kim, Shuiqing Chi, Shao‐tao Tang, Huan Qin, Li Shan Zhou, Peng Chen, Joshua Sung Chih Wong, Kate Ching Ching Chan, Felix Yat Sun Yau, Shu Yan Lam, Calvin Chit Kwong Chow, Tak Wai Wong, C. Chan, Grace Wing-kit Poon, Chun Bong Chow, Wilfred Hing Sang Wong, YL Lau, Gcf Chan, Celine Sze Ling Chui, Xue Li, M. Ho, Ian Chi Kei Wong, Paul Kwong Hang Tam, Kelvin Kai‐Wang To, Jong‐Hyun Kim, Patrick Ip, Mike Yat Wah Kwan
Abstract
= 0.046). 5.4% to 10.8% of patients reported anosmia and ageusia. None developed pediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PMIS-TS). In general, adolescents were more likely to be asymptomatic and less likely to develop fever, but required longer hospital stays. In conclusion, majority patients in this pediatric Asian cohort had a mild disease. None developed PIMS-TS. Their clinical characteristics were influenced by travel history and age.